Live from the NIH registry
Studies recruiting near Toledo right now
Top 25 of 211 recruiting studies, sorted by proximity — each links to its official registry page
Letrozole in Uterine Leiomyosarcoma
Uterine Leiomyosarcoma
Phase 2
Interventional 40 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: GOG Foundation
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
Acute Hereditary Angio Edema
Phase 3
Interventional 124 participants sought
Octapharma Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: Octapharma
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - Alexis — Toledo, Ohio (1.4 mi)
· Sponsor: R1 Therapeutics
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Mercy St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Synairgen Research Ltd.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Taylor Cancer Research Center ( Site 9500) — Maumee, Ohio (7.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: NRG Oncology
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Alleviant Medical, Inc.
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Toledo, Ohio (1.4 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
Mercy Health - St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: DiaMedica Therapeutics Inc
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12063 — Toledo, Ohio (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Mercy Health - St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: PPD Development, LP
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1, Phase 2
Interventional 754 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Revolution Medicines, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: NRG Oncology
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Recurrent or Metastatic Solid Tumors
Phase 1
Interventional 76 participants sought
Research Site — Maumee, Ohio (7.9 mi)
· Sponsor: Daiichi Sankyo
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Toledo, Ohio (1.4 mi)
· Sponsor: Medtronic
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Advanced Medical Research — Maumee, Ohio (7.9 mi)
· Sponsor: Housey Healthcare ULC
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
The University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: Tizona Therapeutics, Inc
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Pulmonary Nodule, Solitary, Lung Cancer
N/A
Observational 2,400 participants sought
Mercy Health St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Veracyte, Inc.
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Phase 2
Interventional 92 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)